Profil
Michael Rudolf worked as a Principal at Biogen, Inc. and Loyola University of Chicago.
He was also the Chief Scientific Officer at Kenta Biotech AG from 2010 to 2013.
Rudolf earned a doctorate degree from the University of Bern in 1996.
Anciens postes connus de Michael Rudolf
| Sociétés | Poste | Fin |
|---|---|---|
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Directeur Technique/Scientifique/R&D | 01/05/2013 |
| Loyola University of Chicago | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Formation de Michael Rudolf
| University of Bern | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
